| PRD_000841 | Name: | CARBOXYPROPYL-BETA-THIOGALACTOSIDE-LYS-PRO-LEUNH2 | Formula: | C26 H48 N5 O9 S | Definition date: | 2015-09-16 | Last modified: | 2015-09-16 |
|
| PRD_001241 | Name: | (BOC)LPA(B27) PEPTIDE | Formula: | C23 H42 N4 O6 S | Definition date: | 2015-09-09 | Last modified: | 2015-09-09 |
|
| PRD_002106 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-4-oxo-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C31 H45 N5 O9 S2 | Definition date: | 2015-07-29 | Last modified: | 2015-07-29 |
|
| PRD_000468 | Name: | Allosamidin | Formula: | C25 H42 N4 O14 | Definition date: | 2015-07-18 | Last modified: | 2022-03-03 |
|
| PRD_002168 | Name: | N-[(benzyloxy)carbonyl]-O-carbamimidamido-L-homoseryl-N-{(3S,4S)-3-hydroxy-6-methyl-1-oxo-1-[(2-phenylethyl)amino]heptan-4-yl}-L-valinamide | Formula: | C34 H51 N7 O7 | Definition date: | 2015-07-15 | Last modified: | 2015-07-15 |
|
| PRD_002103 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C30 H51 N5 O8 S | Definition date: | 2015-07-01 | Last modified: | 2023-11-03 |
|
| PRD_002107 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C31 H47 N5 O8 S2 | Definition date: | 2015-07-01 | Last modified: | 2023-11-03 |
|
| PRD_002146 | Name: | N-[2-(aminomethyl)-5-chlorobenzyl]-1-[(5-methyl-1H-pyrrol-2-yl)carbonyl]-L-prolinamide | Formula: | C19 H23 Cl N4 O2 | Definition date: | 2015-06-17 | Last modified: | 2015-06-17 |
|
| PRD_002174 | Name: | N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-{(2S)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-leucinamide | Formula: | C30 H53 N5 O9 | Definition date: | 2015-06-17 | Last modified: | 2015-06-17 |
|
| PRD_001257 | Name: | para-guanidinomethyl-phenylacetyl-Arg-(3-methylvaline)-Arg-(amidomethyl)benzamidine | Formula: | C36 H59 N15 O4 | Definition date: | 2015-05-27 | Last modified: | 2015-06-22 |
|
| PRD_002159 | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]-L-prolinamide | Formula: | C26 H35 Cl N4 O7 | Definition date: | 2015-05-06 | Last modified: | 2015-05-06 |
|
| PRD_002148 | Name: | 2-methyl-L-alanyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H62 N6 O6 S | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
| PRD_002151 | Name: | 2-methyl-L-alanyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C37 H61 N5 O8 | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
| PRD_002153 | Name: | 2-methyl-L-prolyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H63 N5 O8 | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
| PRD_002154 | Name: | N,2-dimethyl-L-alanyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C38 H63 N5 O8 | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
| PRD_002147 | Name: | N-{(2R,4S,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-leucyl-L-phenylalaninamide | Formula: | C39 H52 N4 O6 | Definition date: | 2015-03-09 | Last modified: | 2015-03-16 |
|
| PRD_001233 | Name: | cyclic-tris-phenylselenazole | Formula: | C36 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001234 | Name: | cyclic-tris-leucylselenazole | Formula: | C27 H36 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001235 | Name: | cyclic-tris-valinylselenazole | Formula: | C24 H30 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_001236 | Name: | cyclic-tris-alanylselenazole | Formula: | C18 H18 N6 O3 Se3 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_002132 | Name: | (10S,13S,16S,19S)-16-benzyl-12-(N-methyl-L-alanyl-L-valyl)-3,14,17-trioxo-2,7,8,9,12,15,18-heptaazatetracyclo[19.2.2.1~6,9~.1~10,13~]heptacosa-1(23),6(27),7,21,24-pentaene-19-carboxylic acid | Formula: | C37 H47 N9 O7 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
| PRD_002133 | Name: | (17S,20S,23S,29S)-20-benzyl-29-{[(2S)-2-(methylamino)propanoyl]amino}-19,22,28-trioxo-2,11-dioxa-5,6,7,18,21,27-hexaazapentacyclo[29.2.2.2~12,15~.1~4,7~.0~23,27~]octatriaconta-1(33),4(38),5,12,14,31,34,36-octaene-17-carboxylic acid (non-preferred name) | Formula: | C42 H50 N8 O8 | Definition date: | 2015-03-04 | Last modified: | 2015-03-04 |
|
| PRD_002139 | Formula: | C51 H80 N7 O16 P S2 | Definition date: | 2015-02-11 | Last modified: | 2023-11-03 |
|
| PRD_001243 | Name: | N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide | Formula: | C40 H61 N5 O7 | Definition date: | 2015-02-04 | Last modified: | 2023-11-03 |
|
| PRD_001256 | Name: | bifunctional peptide | Formula: | C39 H43 N5 O5 | Definition date: | 2015-01-14 | Last modified: | 2015-01-14 |
|